These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

123 related items for PubMed ID: 15765112

  • 1. Graft-versus-host disease of the kidney after rapid tapering of cyclosporin following reduced intensity hematopoietic stem cell transplantation.
    Homma CI, Kami M, Masuo S, Sakiyama M, Kojima R, Hori A, Kusumi E, Katori H, Takeuchi K, Kishi Y, Murashige N, Kim SW, Takaue Y, Mitamura T.
    Bone Marrow Transplant; 2005 May; 35(9):929-30. PubMed ID: 15765112
    [No Abstract] [Full Text] [Related]

  • 2. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D, Martino R, Caballero D, Martin J, Ferra C, Nieto JB, Sampol A, Bernal MT, Piñana JL, Vazquez L, Ribera JM, Besalduch J, Moraleda JM, Carrera D, Brunet MS, Perez-Simón JA, Sierra J.
    J Clin Oncol; 2008 Feb 01; 26(4):577-84. PubMed ID: 18086801
    [Abstract] [Full Text] [Related]

  • 3. Rapid tapering of cyclosporin to maximise the graft-versus-leukaemia effect.
    Shaw PJ, Afify Z.
    Bone Marrow Transplant; 1999 Mar 01; 23(6):632-3. PubMed ID: 10217198
    [No Abstract] [Full Text] [Related]

  • 4. Hematopoietic stem cell transplantation after reduced intensity conditioning in acute myelogenous leukemia patients older than 40 years.
    Huisman C, Meijer E, Petersen EJ, Lokhorst HM, Verdonck LF.
    Biol Blood Marrow Transplant; 2008 Feb 01; 14(2):181-6. PubMed ID: 18215778
    [Abstract] [Full Text] [Related]

  • 5. Acute fulminant myocarditis after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning for acute myelogenous leukemia.
    Nakaseko C, Sakaida E, Ohwada C, Ozawa S, Takeuchi M, Shimizu N, Cho R, Yokota A, Saito Y, Nishimura M.
    Ann Hematol; 2007 Jan 01; 86(1):67-9. PubMed ID: 17021838
    [No Abstract] [Full Text] [Related]

  • 6. Very late appearance of acute graft-versus-host disease after tapering immunosuppression.
    Wollina U, Sayer HG, Wollina K, Graefe T.
    J Dermatol; 2001 Dec 01; 28(12):734-6. PubMed ID: 11804070
    [Abstract] [Full Text] [Related]

  • 7. Feasibility of early tapering of cyclosporine following reduced-intensity stem cell transplantation for advanced hematologic or solid malignancies.
    Hori A, Kami M, Ohnishi M, Murashige N, Kojima R, Takaue Y.
    Haematologica; 2005 Jul 01; 90(7):1001-3. PubMed ID: 15996949
    [Abstract] [Full Text] [Related]

  • 8. Results of syngeneic hematopoietic stem cell transplantation for acute leukemia: risk factors for outcomes of adults transplanted in first complete remission.
    Fouillard L, Labopin M, Gratwohl A, Gluckman E, Frassoni F, Beelen DW, Willemze R, Montserrat E, Blaise D, Atienza AI, Sierra J, Santos M, Gorin NC, Rocha V, Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Haematologica; 2008 Jun 01; 93(6):834-41. PubMed ID: 18469352
    [Abstract] [Full Text] [Related]

  • 9. Graft-versus-host disease: case report and review of literature.
    Jing X, Halat S, Meleg-Smith S.
    J La State Med Soc; 2006 Jun 01; 158(1):20-4. PubMed ID: 16602481
    [Abstract] [Full Text] [Related]

  • 10. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
    Lin Q, Dong M, Wang QM, Wen JY, Wu XY.
    Ai Zheng; 2006 Oct 01; 25(10):1261-5. PubMed ID: 17059772
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic hematopoietic cell transplantation (HCT) following reduced-intensity conditioning in patients with acute leukemias.
    Niederwieser D, Gentilini C, Hegenbart U, Lange T, Becker C, Wang SY, Bartsch K, Pönisch W, Raida M, Al-Ali H.
    Crit Rev Oncol Hematol; 2005 Nov 01; 56(2):275-81. PubMed ID: 16213741
    [Abstract] [Full Text] [Related]

  • 12. A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
    Conrad R, Remberger M, Cederlund K, Ringdén O, Barkholt L.
    Haematologica; 2008 Feb 01; 93(2):265-72. PubMed ID: 18245651
    [Abstract] [Full Text] [Related]

  • 13. Antithymocyte globulin for the prevention of graft-versus-host disease after unrelated hematopoietic stem cell transplantation for acute myeloid leukemia: results from the multicenter German cooperative study group.
    Basara N, Baurmann H, Kolbe K, Yaman A, Labopin M, Burchardt A, Huber C, Fauser AA, Schwerdtfeger R.
    Bone Marrow Transplant; 2005 May 01; 35(10):1011-8. PubMed ID: 15821768
    [Abstract] [Full Text] [Related]

  • 14. Life-threatening acute pancreatitis due to thalidomide therapy for chronic graft-versus-host disease.
    Chung LW, Yeh SP, Hsieh CY, Liao YM, Huang HH, Lin CY, Chiu CF.
    Ann Hematol; 2008 May 01; 87(5):421-3. PubMed ID: 18040684
    [No Abstract] [Full Text] [Related]

  • 15. Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
    Kebriaei P, Kline J, Stock W, Kasza K, Le Beau MM, Larson RA, van Besien K.
    Bone Marrow Transplant; 2005 May 01; 35(10):965-70. PubMed ID: 15806131
    [Abstract] [Full Text] [Related]

  • 16. Steroid-responsive cauda equina syndrome associated with GVHD after allogeneic hematopoietic stem cell transplantation.
    Terrettaz M, Verholen F, Passweg J, Knipp S, Burkhard PR, Chalandon Y.
    Bone Marrow Transplant; 2008 Feb 01; 41(3):315-6. PubMed ID: 17994117
    [No Abstract] [Full Text] [Related]

  • 17. NIH-defined graft-versus-host disease after reduced intensity or myeloablative conditioning in patients with acute myeloid leukemia.
    Terwey TH, Vega-Ruiz A, Hemmati PG, Martus P, Dietz E, le Coutre P, Massenkeil G, Dörken B, Arnold R.
    Leukemia; 2012 Mar 01; 26(3):536-42. PubMed ID: 21869841
    [No Abstract] [Full Text] [Related]

  • 18. Sequential intensified conditioning and tapering of prophylactic immunosuppressants for graft-versus-host disease in allogeneic hematopoietic stem cell transplantation for refractory leukemia.
    Liu QF, Fan ZP, Zhang Y, Jiang ZJ, Wang CY, Xu D, Sun J, Xiao Y, Tan H.
    Biol Blood Marrow Transplant; 2009 Nov 01; 15(11):1376-85. PubMed ID: 19822296
    [Abstract] [Full Text] [Related]

  • 19. Reduced-intensity allogeneic hematopoietic stem cell transplantation for acute leukemias: 'what is the best recipe?'.
    Kassim AA, Chinratanalab W, Ferrara JL, Mineishi S.
    Bone Marrow Transplant; 2005 Oct 01; 36(7):565-74. PubMed ID: 15995714
    [Abstract] [Full Text] [Related]

  • 20. Prospective phase II trial to evaluate the complications and kinetics of chimerism induction following allogeneic hematopoietic stem cell transplantation with fludarabine and busulfan.
    Saito AM, Kami M, Mori S, Kanda Y, Suzuki R, Mineishi S, Takami A, Taniguchi S, Takemoto Y, Hara M, Yamaguchi M, Hino M, Yoshida T, Kim SW, Hori A, Ohashi Y, Takaue Y.
    Am J Hematol; 2007 Oct 01; 82(10):873-80. PubMed ID: 17570513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.